Speaking of credibility... did Jason actually writ
Post# of 30028
Posted On: 01/05/2015 8:25:53 PM
Re: brickbybrick #14339
Speaking of credibility... did Jason actually write this?
Quote:I wasn't aware Retinitis Pigmentosa traded on NASDAQ. It's amazing what one can miss when they have their head is planted in the sand. LOL
Speaking of credibility, the recent news that the U.S. FDA granted MANF an Orphan Drug designation for Retinitis Pigmentosa (NASDAQ:RP) in late December 2014 was a huge win for Amarantus.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼